Stockreport

TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock? [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 5.4% loss over the past four weeks. The [Read more]